Please login to the form below

Not currently logged in
Email:
Password:

CombiHIVvac

This page shows the latest CombiHIVvac news and features for those working in and with pharma, biotech and healthcare.

HIV vaccine from J&J starts human trials

HIV vaccine from J&J starts human trials

Scarcity of funding is also threatening a Russian HIV vaccine candidate called CombiHIVvac, which is heading for phase II testing. .

Latest news

  • Russian HIV vaccine heading for phase II trials Russian HIV vaccine heading for phase II trials

    of CombiHIVvac still needs to be approved by the government, reports the RIA Novosti news agency. ... Mikheyev told reporters that the phase II trials planned for CombiHIVvac could take around two years to complete, provided funding can be found.

More from news
Approximately 1 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
OPEN Access Consulting

OPEN Access Consulting is a specialist market access agency within the OPEN Health Group. As value communications experts we specialise...

Latest intelligence

Alzheimer’s disease – is Europe prepared if a breakthrough treatment becomes available?
Healthcare leaders in the European Union should begin preparing for a breakthrough now...
The UK’s new five-year pricing agreement
Pharma has agreed to capped growth again - in exchange for uptake promises...
Digital applications are transforming the market access landscape
Organisations are leveraging new technology to implement a wider range of business models and, in essence, drive market access success by working smarter, faster and with greater economy....

Infographics